September 22, 2020 – Vection Technologies Ltd. (Vection), a provider of real-time augmented and virtual reality (AR/VR) custom creations and software, has announced that it has signed its first public hospital to trial the company’s augmented reality healthcare solutions.
Vection will collaborate with Italy-based AORN S.G. Moscati hospital and LUISS Business School to introduce AR solutions in the Italian Model for Risk Management in Healthcare promoted by LUISS Business School, a national model that operators must adopt to manage risk in Healthcare.
The trial will focus on integrating Vection’s AR Healthcare solutions within the Moscati hospital, focusing on:
- Real-time integration of data fields from endoscopic equipment in the surgeon’s field of view, through AR wearable devices. The company states that this solution helps to deliver a more precise and safer AR-based navigation system compared to conventional endoscopic procedures;
- Real-time integration of electronic medical record systems with AR, enabling healthcare professionals to access medical information through AR wearable devices.
“We are pleased to have signed this initial trial with Vection Technologies to introduce real-time solutions within the Italian Model for Risk Management in Healthcare,” commented Enzo Peruffo, Associate Dean for Executive Education and Life-Long Learning of Luiss Business School. “Augmented reality represents the key to the digital healthcare transformation, potentially transforming healthcare practices across all critical functions, from training to in-practice usage.” Peruffo added, “We are looking forward to support Vection, and the widespread adoption of these technologies, across the national health system to secure safer outcomes for health professionals and patients alike”
“This initial trial represents the culmination of a lengthy regulatory process with key public stakeholders enabling Vection Technologies to affirm itself at the forefront of the digital healthcare transformation, introducing augmented reality as a new standard in healthcare risk management,” commented Gianmarco Biagi, Managing Director of Vection Technologies. “This agreement represents a key commercial milestone setting the foundations for long-term growth, providing for a strong opportunity for recurring revenue growth during the second half of FY21 and into FY22.”
Vectiondevelops AR applications for tablets, smartphones and wearables with mono or bifocal viewers in order to generate virtual information for viewing in real-life contexts. Devices that the company states its solutions work with include: iPhone, Google Pixel, iPad Pro, Google Glass, Google Tango, Vuzix, Epson Moverio, Microsoft’s HoloLens 1 and HoloLens 2, Magic Leap and more.
Since different devices manage information in a completely different way and offer very different applications to users, Vection identifies the most suitable technology for each individual project to respond to its customers’ needs. The company indicates that the primary applications of its AR solutions are in the areas of remote assistance, staff training, marketing and communication activities.
For more information on Vection Technologies Ltd., please visit the company’s website.
Image credit: Vection Technologies Ltd.
About the author
Sam is the Founder and Managing Editor of Auganix. With a background in research and report writing, he has been covering XR industry news for the past seven years.